Menu
GWAS Study

Association of Genetic Variant at Chromosome 12q23.1 With Neuropathic Pain Susceptibility.

Veluchamy A, Hébert HL, van Zuydam NR et al.

34854908 PubMed ID
GWAS Study Type
433001 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

VA
Veluchamy A
HH
Hébert HL
VZ
van Zuydam NR
PE
Pearson ER
CA
Campbell A
HC
Hayward C
MW
Meng W
MM
McCarthy MI
BD
Bennett DLH
PC
Palmer CNA
SB
Smith BH
Chapter II

Abstract

Summary of the research findings

Importance: Neuropathic pain (NP) has important clinical and socioeconomic consequences for individuals and society. Increasing evidence indicates that genetic factors make a significant contribution to NP, but genome-wide association studies (GWASs) are scant in this field and could help to elucidate susceptibility to NP.

4,512 European ancestry cases, 428,489 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

433001
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.K.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.